Ascentage Pharma, Bayer AG, Blueprint Medicines Corp., and Bristol Myers Squibb Co. are among the key companies NEW YORK, Jan. 25, 2024 /PRNewswire/ — The gastrointestinal stromal tumors therapeutics market is anticipated to grow by USD 1.02 billion, progressing at a CAGR of 6.01% during…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.